Subcutaneous Drug Delivery Market, By Usability (Disposable, and Reusable), By Disease Indication(Auto-immune Disorders, Neurological Disorders, Oncology Disorders, Hormonal Disorders, Allergy & Infectious Disorders, Ophthalmic Disorders, and Others, By Delivery System(Prefilled Syringes, Autoinjector, Pen Injectors, Disposable, and others)By Distribution Channel ( Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
Technological innovations and developments in prefilled syringes and auto-injectors is contributing to the market growth. For instance, Gerresheimer, German manufacturer of primary packaging introduced metal-free Lure Lock Gx RTF Syringe in June 2020, without tungsten to create the perfect primary packaging material for biotechnologically manufactured active ingredients that ideally exclude the possibility of contamination with metal.
Moreover, in March 2022, YpsoMed, medical device companies developed YpsoMate SmartPilot, a reusable attachment to its proprietary YpsoMate pen, which is designed for an easy two-step injection process. The device has a sensor and memory, which is connected to an app, which displays injection timing and doses. The pen provides audio and visual feedback to users. The app can also remind users when it is time to inject the insulin.
Market Dynamics
Product approvals by regulatory authorities is expected to drive the market growth over the forecast period. For instance, on March 6, 2023, Coherus BioSciences, Inc, its global biosimilar company, announced U.S. Food and Drug Administration (FDA) approved a single-dose, prefilled auto injector presentation of UDENYCA (pegfilgrastim-cbqv). The UDENYCA autoinjector has a streamlined, easy-to-use design for use in both in-office and at-home settings of care.
Key features of the study:
This report provides in-depth analysis of the global subcutaneous drug delivery market and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2023–2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the global subcutaneous drug delivery market based on the following parameters–company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Becton Dickinson and Company, Novo Nordisk A/S, Johnson & Johnson, Inc., Novartis International AG, Amgen, Inc., Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche AG, Consort Medical plc, Eli Lilly and Company, Merck & Co., Inc., Insulet Corporation, West Pharmaceutical Services, Inc Gerresheimer AG and other prominent key players.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
Global subcutaneous drug delivery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global subcutaneous drug delivery market
Detailed Segmentation:
Global Subcutaneous Drug Delivery Market, Usability
Disposable
Reusable
Global Subcutaneous Drug Delivery Market, Disease Indication
Auto-immune Disorders
Neurological Disorders
Oncology Disorders
Hormonal Disorders
Allergy & Infectious Disorders
Ophthalmic Disorders
Others
Global Subcutaneous Drug Delivery Market, Delivery System
Prefilled Syringes
Autoinjector
Spring Type
Motorized Type
Wearable Type
Pen Injectors
Disposable
Reusable
Syringes (Injector)
Others (pump, etc.)
Global Subcutaneous Drug Delivery Market, By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Subcutaneous Drug Delivery Market, By Region:
North America
By Country:
U.S.
Canada
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Country:
GCC Countries
Israel
Rest of Middle East
Africa
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Becton Dickinson and Company,
Company Highlights
Products Portfolio
Key Highlights
Financial Performance
Strategies
Novo Nordisk A/S,
Johnson & Johnson
Novartis International AG
Amgen, Inc.
Teva Pharmaceutical Industries Ltd.
F. Hoffmann-La Roche AG.,
Consort Medical plc,
Eli Lilly and Company
Merck & Co., Inc.
Insulet Corporation,
West Pharmaceutical Services, Inc.
Gerresheimer AG
“*” marked represents similar segmentation in other categories in the respective section.
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Usability
Market Snapshot, By Disease Indication
Market Snapshot, By Delivery System
Market Snapshot, By Distribution Channel
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Recent Product Launches
Merger, Acquisition, and Collaborations
Product Launch
Regulatory Scenario
PEST Analysis
4. Global Subcutaneous Drug Delivery Market- Impact of Coronavirus (Covid-19) Pandemic
Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand
5. Global Subcutaneous Drug Delivery Market, By Usability, 2017–2030, (US$ Billion)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segment Trends
Disposable
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
Reusable
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
6. Global Subcutaneous Drug Delivery Market, By Disease Indication , 2017-2030, (US$ Billion)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segment Trends
Auto-immune Disorders
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
Neurological Disorders
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
Oncology Disorders
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
Hormonal Disorders
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
Allergy & Infectious Disorders
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
Ophthalmic Disorders
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
7. Global Subcutaneous Drug Delivery Market, By Delivery System, 2017-2030, (US$ Billion)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segment Trends
Prefilled Syringes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
Auto injector
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
Pen Injectors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
Disposable
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
Others (pump, etc.)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
8. Global Subcutaneous Drug Delivery Market, By Distribution Channel, 2017-2030, (US$ Billion)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
9. Global Subcutaneous Drug Delivery Market, By Region, 2017–2030, (US$ Billion)
Overview
Market Share Analysis, By Region, 2023 and 2030 (%)
Y-o-Y Growth Analysis, For Region, 2017–2030
Regional Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Usability , 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Delivery System , 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017- 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017– 2030, (US$ Billion)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Usability , 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Delivery System , 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017- 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017– 2030, (US$ Billion)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Usability , 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Delivery System , 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017- 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017– 2030, (US$ Billion)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Usability , 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Delivery System , 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017- 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017– 2030, (US$ Billion)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Usability , 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Delivery System , 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017- 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017– 2030, (US$ Billion)
GCC Countries
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Usability , 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Delivery System , 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017- 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017– 2030, (US$ Billion)
North Africa
Central Africa
South Africa
10. Competitive Landscape
Company Profiles
Becton Dickinson and Company
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Novo Nordisk A/S
Johnson & Johnson.
Novartis International AG
Amgen, Inc
Teva Pharmaceutical Industries Ltd.
F. Hoffmann-La Roche AG.
Consort Medical plc.
LaVision Biotec GmbH
Eli Lilly and Company
Merck & Co., Inc.
Insulet Corporation
West Pharmaceutical Services, Inc.
Gerresheimer AG.
11. Section
References
Research Methodology
About us and Sales Contact
*Browse 22 market data tables and 18 figures on “Global Subcutaneous Drug Delivery Market”- Global forecast to 2030.